Free Trial

Trinity Biotech (TRIB) Short Interest Ratio & Short Volume

Trinity Biotech logo
$0.58 -0.06 (-8.74%)
As of 11:10 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Trinity Biotech Short Interest Data

Trinity Biotech (TRIB) has a short interest of 146,300 shares, representing 1.33% of the float (the number of shares available for trading by the public). This marks a -8.16% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 913,478 shares to cover all short positions.

Current Short Interest
146,300 shares
Previous Short Interest
159,300 shares
Change Vs. Previous Month
-8.16%
Dollar Volume Sold Short
$100,230.13
Short Interest Ratio
0.1 Days to Cover
Last Record Date
March 15, 2025
Outstanding Shares
18,054,000 shares
Float Size
10,960,000 shares
Short Percent of Float
1.33%
Today's Trading Volume
18,456 shares
Average Trading Volume
913,478 shares
Today's Volume Vs. Average
2%
Short Selling Trinity Biotech?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Trinity Biotech and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

TRIB Short Interest Over Time

TRIB Days to Cover Over Time

TRIB Percentage of Float Shorted Over Time

Remove Ads

Trinity Biotech Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/15/2025146,300 shares $100,230.13 -8.2%1.3%0.1 $0.69
2/28/2025159,300 shares $116,448.30 -59.9%1.5%0.1 $0.73
2/15/2025396,900 shares $301,644.00 -33.5%3.6%0.2 $0.76
1/31/2025596,800 shares $537,120.00 +921.9%5.3%0.3 $0.90
1/15/202558,400 shares $46,603.20 +100.7%0.5%0.3 $0.80
12/31/202429,100 shares $25,613.82 -50.3%0.3%0.1 $0.88
12/15/202458,500 shares $52,942.50 -17.1%0.5%0.3 $0.91
11/30/202470,600 shares $77,660.00 -8.2%0.6%0.4 $1.10
11/15/202476,900 shares $105,353.00 -18.3%0.7%0.1 $1.37
10/31/202494,100 shares $165,616.00 -23.1%0.9%0.1 $1.76
10/15/2024122,300 shares $205,720.83 +22.3%1.1%0.1 $1.68
9/30/2024100,000 shares $110,000.00 +11.5%0.9%0.1 $1.10
9/15/202489,700 shares $143,520.00 -57.9%0.8%0.1 $1.60
8/31/2024213,200 shares $424,268.00 +1,232.5%1.8%0.2 $1.99
8/15/202416,000 shares $36,800.00 -25.6%0.2%0.3 $2.30
7/31/202421,500 shares $64,070.00 +16.9%0.3%0.4 $2.98
7/15/202418,400 shares $56,304.00 +70.4%0.3%0.4 $3.06
6/30/202410,800 shares $23,004.00 -71.5%0.2%0.2 $2.13
6/15/202437,900 shares $105,362.00 +213.2%0.5%0.9 $2.78
5/31/202412,100 shares $20,328.00 +63.5%0.2%0.5 $1.68
5/15/20247,400 shares $11,248.00 +516.7%0.1%0.4 $1.52
4/30/20241,200 shares $2,184.00 -36.8%0.0%0.1 $1.82
4/15/20241,900 shares $3,629.00 +58.3%0.0%0 $1.91
3/31/20241,200 shares $2,448.00 -72.1%0.0%0 $2.04
3/15/20244,300 shares $9,718.00 -71.9%0.1%0 $2.26
2/29/202415,300 shares $33,354.00 -5.0%0.2%0.2 $2.18
2/15/202416,100 shares $41,135.50 -46.9%N/A0.2 $2.56
1/31/202430,300 shares $17,877.00 +3.1%N/A0.1 $0.59
1/15/202429,400 shares $14,112.00 +92.2%N/A0.6 $0.48
12/31/202315,300 shares $6,563.70 -72.6%N/A0.3 $0.43
12/15/202355,800 shares $27,844.20 -14.6%N/A1.2 $0.50
11/30/202365,300 shares $31,148.10 +9.4%N/A1.8 $0.48
11/15/202359,700 shares $25,611.30 +70.1%N/A2.2 $0.43
10/31/202335,100 shares $16,146.00 +9.4%N/A1.3 $0.46
10/15/202332,100 shares $16,820.40 +23.0%N/A0.8 $0.52
9/30/202326,100 shares $19,186.11 +6.1%N/A0.6 $0.74
9/15/202324,600 shares $17,736.60 -1.6%N/A0.4 $0.72
8/31/202325,000 shares $20,000.00 +20.2%N/A0.4 $0.80
8/15/202320,800 shares $14,913.60 -59.9%N/A0.3 $0.72
7/31/202351,800 shares $49,210.00 +3.2%N/A0.8 $0.95
Musk’s real agenda in D.C. (Ad)

In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of America…

7/15/202350,200 shares $42,670.00 +27.4%N/A0.8 $0.85
6/30/202339,400 shares $37,473.34 -8.4%N/A0.8 $0.95
6/15/202343,000 shares $44,720.00 +91.1%N/A1 $1.04
5/31/202322,500 shares $20,925.00 -23.5%N/A0.5 $0.93
5/15/202329,400 shares $27,606.60 -18.3%N/A0.8 $0.94
4/30/202336,000 shares $37,972.80 -6.7%N/A1.1 $1.05
4/15/202338,600 shares $32,427.86 +33.1%N/A1.3 $0.84
3/31/202329,000 shares $27,260.00 -23.1%N/A1.2 $0.94
3/15/202337,700 shares $36,188.23 +10.9%N/A1.5 $0.96
2/28/202334,000 shares $35,870.00 -11.9%N/A1.3 $1.06
2/15/202338,600 shares $41,109.00 -1.5%N/A1.5 $1.07
1/31/202339,200 shares $42,140.00 -35.3%N/A1.3 $1.08
1/15/202360,600 shares $64,236.00 -19.8%N/A1.8 $1.06
12/30/202275,600 shares $74,844.00 -5.4%N/A2.3 $0.99
12/15/202279,900 shares $92,684.00 -23.8%N/A2.4 $1.16
11/30/2022104,900 shares $139,517.00 -22.0%N/A3.2 $1.33
11/15/2022134,400 shares $178,752.00 -2.9%N/A3.7 $1.33
10/31/2022138,400 shares $160,544.00 -17.1%N/A4.2 $1.16
10/15/2022166,900 shares $198,627.69 -12.7%N/A4.7 $1.19
9/30/2022191,200 shares $204,775.20 -12.1%N/A5.2 $1.07
9/15/2022217,400 shares $256,532.00 -13.9%N/A5.3 $1.18
8/31/2022252,500 shares $308,050.00 -13.4%N/A5.8 $1.22
8/15/2022291,700 shares $402,546.00 -19.6%N/A6.1 $1.38
7/31/2022362,800 shares $493,408.00 -19.8%N/A5.9 $1.36
7/15/2022452,600 shares $624,588.00 +1.0%N/A4.7 $1.38
6/30/2022448,100 shares $551,163.00 -6.4%N/A0.7 $1.23
6/15/2022478,700 shares $588,801.00 +2.9%N/A0.7 $1.23
5/31/2022465,100 shares $660,442.00 +10.6%N/A0.7 $1.42
5/15/2022420,600 shares $492,102.00 +1.8%N/A0.6 $1.17
4/30/2022413,100 shares $491,589.00 -34.1%N/A0.6 $1.19
4/15/2022626,900 shares $764,818.00 +246.0%N/A0.9 $1.22
3/31/2022181,200 shares $192,072.00 -23.2%N/A1.4 $1.06
3/15/2022235,800 shares $231,060.42 +6.5%N/A1.8 $0.98
2/28/2022221,400 shares $225,828.00 +32.1%N/A1.5 $1.02
2/15/2022167,600 shares $191,064.00 -20.2%N/A1.2 $1.14
1/31/2022210,100 shares $241,615.00 -73.4%N/A1.8 $1.15
1/15/2022790,500 shares $1.09 million +36.5%N/A7.2 $1.39
12/31/2021579,200 shares $828,256.00 +103.8%N/A5.4 $1.43
12/15/2021284,200 shares $477,456.00 -7.3%N/A2.6 $1.68
11/30/2021306,400 shares $566,840.00 +4.2%N/A2.8 $1.85
11/15/2021294,000 shares $585,060.00 -9.4%N/A2.6 $1.99
10/29/2021324,600 shares $668,676.00 +10.5%N/A2.5 $2.06
10/15/2021293,900 shares $596,617.00 +5.2%N/A1.8 $2.03
9/30/2021279,300 shares $603,288.00 +0.0%N/A1.3 $2.16
9/15/2021279,200 shares $664,496.00 -14.9%N/A1.4 $2.38
8/31/2021327,900 shares $855,819.00 +23.4%N/A1.6 $2.61
8/13/2021265,700 shares $581,883.00 -0.2%N/A1.4 $2.19
7/30/2021266,300 shares $583,197.00 +4.6%1.3%1 $2.19
7/15/2021254,500 shares $521,725.00 -10.1%1.2%1 $2.05
6/30/2021283,200 shares $832,608.00 -1.9%1.4%1.3 $2.94
Musk’s real agenda in D.C. (Ad)

In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of America…

6/15/2021288,800 shares $901,056.00 -13.7%1.4%1 $3.12
5/28/2021334,700 shares $1.05 million +19.7%1.6%1.1 $3.13
5/14/2021279,600 shares $939,456.00 -18.0%1.4%0.8 $3.36
4/30/2021340,900 shares $1.17 million -17.7%1.7%1.1 $3.43
4/15/2021414,200 shares $1.61 million +13.5%2.0%0.8 $3.88
3/31/2021364,900 shares $1.44 million -3.0%1.8%0.7 $3.95
3/15/2021376,300 shares $1.73 million +45.8%1.8%0.8 $4.61
2/26/2021258,100 shares $1.36 million +59.1%N/A0.6 $5.28
2/12/2021162,200 shares $981,310.00 +22.0%0.8%0.3 $6.05
1/29/2021133,000 shares $573,230.00 +4.7%N/A0.3 $4.31
1/15/2021127,000 shares $514,350.00 -15.3%N/A0.4 $4.05
12/31/2020150,000 shares $582,000.00 +32.4%N/A0.5 $3.88
12/15/2020113,300 shares $491,722.00 +0.7%N/A0.4 $4.34
11/30/2020112,500 shares $497,250.00 +72.0%N/A0.3 $4.42
11/15/202065,400 shares $197,508.00 +15.8%N/A0.2 $3.02
10/30/202056,500 shares $155,940.00 +52.7%N/A0.1 $2.76
10/15/202037,000 shares $96,570.00 +56.8%N/A0.1 $2.61
9/30/202023,600 shares $47,672.00 -62.1%N/A0 $2.02
9/15/202062,300 shares $141,421.00 -54.4%N/A0.1 $2.27
8/31/2020136,700 shares $263,831.00 -75.6%N/A0.2 $1.93
8/14/2020560,200 shares $1.28 million -0.7%N/A0.5 $2.28
7/31/2020564,400 shares $1.41 million -12.6%N/A0.6 $2.49
7/15/2020646,000 shares $1.64 million -2.2%N/A0.7 $2.54
6/30/2020660,700 shares $1.44 million -5.6%N/A0.7 $2.18
6/15/2020699,700 shares $1.36 million +14.4%N/A0.7 $1.95
5/29/2020611,500 shares $776,605.00 -3.0%N/A0.7 $1.27
5/15/2020630,300 shares $945,450.00 +25.4%N/A0.6 $1.50
4/30/2020502,800 shares $799,452.00 +130.4%N/A0.6 $1.59
4/15/2020218,200 shares $235,656.00 +75.3%N/A0.3 $1.08
3/31/2020124,500 shares $170,565.00 -35.7%N/A0.2 $1.37

TRIB Short Interest - Frequently Asked Questions

What is Trinity Biotech's current short interest?

Short interest is the volume of Trinity Biotech shares that have been sold short but have not yet been closed out or covered. As of March 15th, investors have sold 146,300 shares of TRIB short. 1.33% of Trinity Biotech's shares are currently sold short. Learn More on Trinity Biotech's current short interest.

Which institutional investors are shorting Trinity Biotech?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Trinity Biotech: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Trinity Biotech?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.33% of Trinity Biotech's floating shares are currently sold short.

Is Trinity Biotech's short interest increasing or decreasing?

Trinity Biotech saw a drop in short interest during the month of March. As of March 15th, there was short interest totaling 146,300 shares, a drop of 8.2% from the previous total of 159,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Trinity Biotech's float size?

Trinity Biotech currently has issued a total of 18,054,000 shares. Some of Trinity Biotech's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Trinity Biotech currently has a public float of 10,960,000 shares.

How does Trinity Biotech's short interest compare to its competitors?

1.33% of Trinity Biotech's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Trinity Biotech: Verrica Pharmaceuticals Inc. (8.48%), Outlook Therapeutics, Inc. (19.15%), Repare Therapeutics Inc. (3.28%), Kezar Life Sciences, Inc. (0.97%), Spero Therapeutics, Inc. (0.84%), Celularity Inc. (11.85%), Connect Biopharma Holdings Limited (0.02%), Precision BioSciences, Inc. (17.87%), ImmuCell Co. (0.23%), Lantern Pharma Inc. (2.98%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks.

What does it mean to sell short Trinity Biotech stock?

Short selling TRIB is an investing strategy that aims to generate trading profit from Trinity Biotech as its price is falling. TRIB shares are trading down $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Trinity Biotech?

A short squeeze for Trinity Biotech occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TRIB, which in turn drives the price of the stock up even further.

How often is Trinity Biotech's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TRIB, twice per month. The most recent reporting period available is March, 15 2025.




This page (NASDAQ:TRIB) was last updated on 3/31/2025 by MarketBeat.com Staff
From Our Partners